Menu

The Medicaid DSH Program

The Medicaid Disproportionate Share Hospital (DSH) program is an important component of the United States' broader effort to provide healthcare to its most disadvantaged citizens. Initiated to offset the financial burdens faced by hospitals delivering care to uninsured and low-income patients, DSH payments have become a cornerstone of funding for many safety-net hospitals. However, while [...] Read More

The Medicare DSH Program

The counterpart to Medicaid’s Disproportionate Share Hospital (DSH) program, Medicare’s DSH program was established with the shared objective of providing financial support to hospitals that serve a large number of low-income patients. Yet, despite this common purpose, the two programs differ significantly in terms of operational frameworks, eligibility criteria, and policy issues. Background The impetus [...] Read More

White House Releases Full Budget Request for Fiscal Year 2025, Proposing to Extend Medicare Trust Fund Solvency, Advance Health Equity, and Expand Access to Care While Lowering Costs

On March 11, 2024, the White House released the President’s fiscal year (FY) 2025 budget, which builds upon the priorities included in the Infrastructure Investment and Jobs Act (Bipartisan Infrastructure Law),[1] CHIPS and Science Act,[2] and the Inflation Reduction Act (IRA).[3] For the Department of Health and Human Services (HHS), the Administration is requesting $130.7 [...] Read More

Prior authorizations in Medicare Advantage

As the Centers for Medicare & Medicaid Services (CMS) has contracted with private health insurance plans for the provision of managed care options under the Medicare Advantage (MA) program, these plans have not unexpectedly brought commercial insurance’s utilization management practices to Medicare. Chief among these is prior authorization, the process under which health plans can [...] Read More

The Debate over Step Therapy

Step therapy is the process under which a health insurance plan requires a patient to try one or more alternative—typically lower cost— drugs or treatment options before they can access the prescription which their physician has identified as the optimal treatment option for their diagnosis. For AHIP, the association representing America’s health plans, the stepwise [...] Read More

CMS Finalizes CY 2023 Policy Changes for Medicare Advantage and Part D Plans; Including Patient Cost-Sharing, Patient Protections, and Provider Accessibility

On April 29, 2022, the Centers for Medicare & Medicaid Services (CMS) released its final rule and a fact sheet, containing policies for Medicare Advantage (MA) and Medicare Part D plans in CY (contract year) 2023. The rule includes the following changes: Redefining ‘negotiated price’ for Part D drugs so prices at point of sale [...] Read More